Can Immune Therapy Cure Acute Myeloid Leukemia? Robert Peter Gale LEUKEMIA (PH WIERNIK, SECTION EDITOR) Open access 22 March 2023 Pages: 381 - 386
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes Chen WangDavid A. Sallman Leukemia (PH Wiernik, Section Editor) 25 March 2023 Pages: 387 - 408
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect Yuxin AnXin JinMingfeng Zhao Leukemia (PH Wiernik, Section Editor) 03 April 2023 Pages: 409 - 441
Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead Thomas GrindaElie RassyBarbara Pistilli ReviewPaper Open access 25 March 2023 Pages: 442 - 465
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead Thomas GrindaElie RassyBarbara Pistilli Correction Open access 18 April 2023 Pages: 466 - 467
HER2-Low Breast Cancer: a New Subtype? Chiara CortiFederica GiuglianoGiuseppe Curigliano ReviewPaper 27 March 2023 Pages: 468 - 478
Individualizing Curative-Intent Therapy in HER2-Positive Early-Stage Breast Cancer Olga Martínez-SáezAdrienne G. Waks ReviewPaper 30 March 2023 Pages: 479 - 495
Therapeutic Cancer Vaccines for Nonmelanoma Skin Cancer Shou-En WuYi-Hsien ChenBing-Heng Yang ReviewPaper 28 March 2023 Pages: 496 - 514
Response Evaluation of Neoadjuvant Therapies in Sarcoma Caroline R. MedinKenneth Cardona ReviewPaper 28 March 2023 Pages: 515 - 527
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed? Steven BialickLeticia CampoverdeGina D’Amato ReviewPaper 05 April 2023 Pages: 528 - 541
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence Gregg A. Robbins-WeltyJason A. WebbThomas W. LeBlanc ReviewPaper 05 April 2023 Pages: 542 - 564
